ABBV

AbbVie Inc

drug manufacturers - general

Current price

$258.15

+28.02% over 1Y

Ticker pages are provided for informational and educational purposes.

Market cap

$464.58B

Exchange

NYSE

Headquarters

IL, UNITED STATES

About ABBV

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Latest news

Sourced via Alpha Vantage

Reuters · 22h ago

China approves J&J psoriasis pill Icotyde, says drugmaker

Stock Titan · 1d ago

AbbVie seeks EMA approval to let Crohn’s patients use SKYRIZI shots

MarketWatch · 1d ago

AbbVie Inc. stock outperforms competitors despite losses on the day

Trefis · 1d ago

Has AbbVie Stock Become Too Expensive to Buy?

Ad-hoc-news.de · 1d ago

AbbVie stock trades near 52-week high as Q2 2026 immunology growth lifts earnings

marketscreener.com · 2d ago

Gubra Flags $50 Million Milestone Payment as AbbVie Begins Phase 2 Study of Obesity Drug

Investing.com Canada · 2d ago

Avalo Therapeutics CFO sells over $1.45 million in stock By Investing.com

Simply Wall Street · 2d ago

Is Amgen (AMGN) Refocusing Its R&D Portfolio With The Exit From TScan’s Crohn’s Deal?